Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OKE | ENB |
|---|---|---|
| Price | $90.79 | $47.38 |
| Change today | ▲ 0.28% | ▼ 0.99% |
| Market cap | $57.23B | $105.59B |
| Return, 3 months | +5.2% | -11.9% |
| Return, year to date | +28.2% | +7.3% |
| Return, 1 year | +29.9% | +6.2% |
| P/E (TTM) | 15.7 | 25.7 |
| P/B | 2.5 | 2.5 |
| P/E percentile vs own 5y | 52nd | 75th |
| Dividend yield | 4.63% | 5.69% |
| Revenue growth (YoY, latest qtr) | +52.8% | +97.1% |
| Net profit growth (YoY) | +13.4% | -32.4% |
| Gross margin | 23.3% | 25.7% |
| Operating margin | 15.6% | 13.6% |
| Net margin | 9.3% | 6.8% |
| Return on equity | 16.3% | 9.7% |
| Analyst target vs. price | +11.6% | +21.7% |
| Analyst buy share | 36% | 57% |
| RSI (14) | 43 | 38 |
| 30-day volatility | 22.9% | 19.0% |
| Max drawdown, 1 year | -11.9% | -15.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.